Lorvacs XL is a brand name for the extended-release formulation of the medication lercanidipine, which belongs to a class of drugs known as calcium channel blockers. It is primarily prescribed for the treatment of hypertension (high blood pressure). By inhibiting the influx of calcium ions into vascular smooth muscle cells, Lorvacs XL causes the muscles to relax, leading to a dilation of peripheral arteries. This action helps in reducing the blood pressure, making it easier for the heart to pump blood and reducing the risk of cardiovascular events such as heart attacks and strokes. The extended-release formulation of this medication allows for once-daily dosing, which can improve patient compliance by simplifying the treatment regimen. As with any medication, it is important to use Lorvacs XL under the guidance of a healthcare professional to ensure its safe and effective use.